{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Hayward",
      "state": "CA",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "74953",
      "recalling_firm": "Impax Laboratories, Inc.",
      "address_1": "31153 San Antonio Street",
      "address_2": "N/A",
      "postal_code": "94544",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Distributed Nationwide",
      "recall_number": "D-0215-2017",
      "product_description": "Lamotrigine Orally Disintegrating Tablets (ODT), 200 mg, 30 Tablets 3 blisters containing 10 tablets each, Rx only, Manufactured by: Watson Pharma Private Ltd., Verna, Salcette Goa INDIA, Distributed by: Impax Generics, Hayward, CA",
      "product_quantity": "3,074 boxes (30 count boxes)",
      "reason_for_recall": "Labeling; Label Mixup; box labeled to contain 200 mg blister packs but actually contain 100 mg blister packs",
      "recall_initiation_date": "20160819",
      "center_classification_date": "20161222",
      "termination_date": "20170601",
      "report_date": "20161228",
      "code_info": "Lot Number 502240, expiry date 11/2017"
    }
  ]
}